NSE: JYOTHYLAB | BSE: 532926

Expensive Underperformer

Download real time

349.75 1.25 (0.36%)

41.30% Fall from 52W High

247.8K NSE+BSE Volume

NSE 19 May, 2025 12:29 PM (IST)

12,843.3

Market Cap

Below industry Median

0.5

Beta 1Year

Very Low volatility

Jyothy Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JYOTHYLAB, BSE:532926 Jyothy Labs Ltd.

Jyothy Labs Ltd.

05 Jun 2020

349.75

0.36%

Jyothy Labs

Buy: Jyothy Labs Ltd.

Recommendation Target

Sharekhan

Jyothy Labs Limited (JLL) registered disappointing performance in Q4FY2020, with consolidated revenues and PAT declining by ~24% and 60%, (volumes fell by 22%). OPM dropped by 544 bps to 10.3% affected by lower operating leverage. The inventory filling of seasonal products such as household insecticides (Maxo mosquito repellents) and soaps (Margo) with distributors was affected by lockdown at the end of March 2020 (impact on revenues and PAT was Rs. 150 crore and Rs. 50 crore respectively). However, with strong leftover inventory, April and May saw sales growing y-o-y despite lower...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

07 Feb 2020

349.75

0.36%

JYOTHY LABS LIMITED

Accumulate: Jyothy Labs Ltd.

Target

Geojit BNP Paribas

Jyothy Laboratories Ltd (JLL) is an Indian FMCG player with products across Fabric care, Dishwashing, Mosquito repellents & Personal Care. We maintain our Accumulate rating with a revised target of Rs169 on account of recent fall in valuation. JLL's revenue de-grew by 5.9%YoY for Q3FY20 led by demand...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

05 Feb 2020

349.75

0.36%

Significant miss on all fronts; Outlook unclear

Neutral: Jyothy Labs Ltd.

Target

Motilal Oswal

5 February 2020 Jyothy Labroratories (JYL) 3QFY20 results were disappointing on all fronts. According to management, part of the impact was due to unusually low off- take in the CDS channel, which should normalize in the next quarter. With weak earnings growth expectations even on a low base and low RoEs compared to peers, we believe that valuations, while at discount to peers, are justified. EBITDA declined 9.3% YoY to INR651m (v/s est. PBT declined 24% YoY to INR441m (v/s est.

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

29 Oct 2019

349.75

0.36%

Jyothy Labs Ltd. - Result Update - 29 October 2019

Hold: Jyothy Labs Ltd.

Way2Wealth

Jyothy Labs Ltd. (Formerly known as Jyothy Laboratories Ltd.) declared its Q2FY20 results recently. The key highlights are as follows: 1. The company reported 8.5% Y-O-Y growth in net sales to `475crs. The Non-HI business grew by 10% Y-O-Y. Volume growth for the quarter was at 8.3% Y-O-Y. 2. EBIDTA expanded by 11% to `79crs Y-O-Y. Reported net profit for the quarter was at...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Jyothy Labs Ltd.

23 Oct 2019

349.75

0.36%

Jyothy Laboratories

Hold: Jyothy Labs Ltd.

Target

ICICI Securities Limited

Fabric care, dishwashing improves; HI continues to depress Fabric care (40% of sales) witnessed growth of 13.1% YoY on account of strong performance of the Ujala brand. Ujala Supreme market share increased to 82.1% in Q2FY20 vs. 81.2% in Q4FY19 while Ujala IDD market share remained flat at 15.5% during the period. Ujala Crisp & Shine witnessed strong growth of 24.8% YoY during the quarter. The dishwash segment witnessed strong growth of 8.6% YoY on account of 9% YoY growth in Exo and Pril. HI segment declined 1.2% YoY mainly on account of...

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

22 Oct 2019

349.75

0.36%

Revenue in line; operating performance below estimates

Neutral: Jyothy Labs Ltd.

Target

Motilal Oswal

22 October 2019 to INR4.6b (v/s est. EBITDA grew 8.1% YoY to INR791m (v/s est. INR836m) while Adj. PAT grew 17.4% YoY to INR532m (v/s est. Fabric care/Dishwashing/Personal care sales grew 13.1%/8.6%/6.9% while Household Insecticides (HI) sales were down 1.2% YoY.

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

26 Jul 2019

349.75

0.36%

Jyothy Labs Ltd. - Result Update - 26 July 2019

Hold: Jyothy Labs Ltd.

Way2Wealth

1. Jyothy Labs (JLL) reported a 2.2% Y-O-Y growth in net sales to `423crs. The Non-HI business grew by 4.2% Y-O-Y. Volume growth for the quarter was at 5.6% YoY. 2. EBIDTA expanded by 16% to `65.6crs due to expansion in gross margin. Reported net...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

25 Jul 2019

349.75

0.36%

JYOTHY LABS LIMITED

Accumulate: Jyothy Labs Ltd.

Target

Geojit BNP Paribas

Jyothy Laboratories Ltd (JLL) is an Indian FMCG player with products across Fabric care, Dishwashing, Mosquito repellents & Personal Care. JLL's revenue grew by a mere 2.2%YoY for Q1FY20 despite volume growth of 5.6% due to increased offers in premium brands....

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

24 Jul 2019

349.75

0.36%

Jyothy Laboratories

Hold: Jyothy Labs Ltd.

Recommendation Target

ICICI Securities Limited

Personal care shines backed by Margo's Naturals' proposition After three quarters of muted growth, JLL's strategy to focus on naturals space has started yielding results with personal care segment outperforming other segments (13.3% growth YoY) in an otherwise lacklustre market. Through its brands Margo soap, Fa, Neem toothpaste, the company has a substantial presence in the naturals' category in a few southern states and West Bengal. With Margo growing at 18% CAGR in the last few years, we believe strong growth will continue due to the structural trend of Naturals'...

Jyothy Labs Ltd. has an average target of 461.00 from 5 brokers.

Jyothy Labs Ltd.

23 Jul 2019

349.75

0.36%

Jyothy Labs

Hold: Jyothy Labs Ltd.

Sharekhan

Jyothy Labs Limited (JLL) registered a mixed performance in Q1FY2020, with revenue growing in low single digits (as household insecticide [HI] revenue declined by 22 %). However, operating margin (OPM) grew by 144 bps to 15.9%, mainly on account of lower other expenses, as the company shifted to Ind- AS 116. On a comparable basis, OPM was almost flat at 14.7% in Q1FY2020. The HI category will take time to revive, while the dishwashing and fabric care categories will continue to grow at a good pace, aided by new launches and a...

Motilal Oswal decreased Neutral price target of Jyothy Labs Ltd. to 375.0 on 12 May, 2025.

Is Jyothy Labs Ltd. worth buying?

280 Votes:

Buy 80.71%

Sell 11.43%

Hold 7.86%

RESEARCH REPORTS

Neutral SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf